This study design is subject to relevant SFDA regulations about clinical trials. Patients will be screened for inclusion into the study at the initial visit(240 patients to be recruited) and then undergo a minimum of 3-7 day's placebo washout period(placebo wash out is to eliminate the effect of prior antipsychotic medication with tablets without any active ingredients)(patients without prior antipsychotic medication are exempt from the washout phase). After screening and washout period, eligible patients will be randomly assigned to the two treatment group, Aripiprazole or Risperidone, for 6 week's treatment. Patients will be hospitalized for the entire duration of the study. Patients' condition will be assessed weekly.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
240
Guangzhou Brain Hospital
Guangzhou, Guangdong, China
Psychiatry Dept. People's Hospital, Wuhan University
Wuhan, Hubei, China
Mental Health Hospital, Nanjing Medical University
Nanjing, Jiangsu, China
Anding Hosp. Capital University of Medical Science
Beijing, China
Institute of Mental Health, Peking University
Beijing, China
Shanghai Mental Health Center
Shanghai, China
Deduction rate of PANSS total
PANSS positive
PANSS negative
CGI
CGI improvement
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.